Solvonis Therapeutics plc (LON:SVNS)
0.1405
+0.0055 (4.07%)
Aug 12, 2026, 11:00 AM GMT
Solvonis Therapeutics Employees
Solvonis Therapeutics had 6 employees as of December 31, 2025. The number of employees increased by 3 or 100.00% compared to the previous year.
Employees
6
Change (1Y)
3
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-956.67K GBP
Market Cap
9.19M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6 | 3 | 100.00% |
| Dec 31, 2024 | 3 | -4 | -57.14% |
| Dec 31, 2023 | 7 | -2 | -22.22% |
| Dec 31, 2022 | 9 | -1 | -10.00% |
| Dec 31, 2021 | 10 | 1 | 11.11% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IXICO | 79 |
| Oxford BioDynamics | 37 |
| Aptamer Group | 30 |
| Palatin Technologies | 29 |
| Fusion Antibodies | 24 |
| OptiBiotix Health | 9 |
| Theracryf | 9 |
| Genflow Biosciences | 5 |